Fitness cost of ceftazidime-avibactam resistance acquisition in carbapenem-resistant hypervirulent Klebsiella pneumoniae. [PDF]
Huang M +6 more
europepmc +1 more source
Ceftazidime/Avibactam Monotherapy Versus Other Antibiotics: Where Do We Stand? [PDF]
Vougiouklakis G +5 more
europepmc +1 more source
Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China. [PDF]
Qin X +20 more
europepmc +1 more source
Prevalence, Antimicrobial Susceptibility, and Molecular Characteristics of Ceftazidime-Avibactam-Resistant <i>Klebsiella pneumoniae</i> in a Chinese Hospital. [PDF]
Li J +7 more
europepmc +1 more source
Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]
Karunanidhi A +10 more
europepmc +1 more source
Allergy to ceftazidime/avibactam: diagnosis and desensitization
Cristallo, Mattia +4 more
openaire +2 more sources
Ceftazidime-Avibactam in Critically Ill Patients: A Multicenter Observational Study. [PDF]
Silvia O +12 more
europepmc +1 more source
Ceftazidime-Avibactam: A Retrospective Analysis of Multicenter Real-World Data and Factors Affecting Mortality. [PDF]
Aktuğ Demir N +22 more
europepmc +1 more source
Antimicrobial Susceptibility of Ceftazidime-Avibactam in Clinical Isolates of Carbapenemase-Producing Enterobacterales. [PDF]
Jain S, Vyas A, Chaturvedi P.
europepmc +1 more source
Pharmacokinetic Changes of Ceftazidime-Avibactam with Veno-Arterial Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Severe Renal Impairment: A Case Report. [PDF]
Shen Z, Qin H, Li Q, Mao X.
europepmc +1 more source

